Imaging Retinal Vasculature in Infant Eyes

Part of paid clinical trials in Durham, North Carolina.

Sponsor
Duke University
Study ID
NCT05558059
Status
Recruiting

Conditions

  • Retinopathy of Prematurity

Eligibility Criteria

Sex
ALL
Age
N/A - 2 Months
Healthy Volunteers
Not accepted

Interventions

  • Handheld Optical Coherence Tomography with OCT Angiography — DEVICE
    OCT systems are in vivo optical imaging technology that allows non-contact imaging of early-stage ocular pathology. They create real-time, non-invasive images of ocular microstructure and have become standard-of-care instruments in ophthalmic imaging in clinics and operating rooms. In contrast to the visible light used in clinical eye examinations, because infrared light is not visible, the participant is not disturbed by the light. OCT imaging allows the capture of hundreds of B-scan (cross-sectional) images in seconds. These B-scans are analyzed for depth-resolved information and can also be stacked to create a volume and the stack may be summed up to create a retinal image. OCT angiography (OCTA) is an extension of the OCT systems, by taking images at the same location over time to extract retinal vascular flow information. It has been utilized to assess the ocular blood flow in many adult and pediatric patients.

Study Details

Retinopathy of prematurity is a leading cause of childhood blindness worldwide. The fovea, a critical location in the retina determining visual acuity and visual function, and the blood vessels around it, are abnormally developed in infants with retinopathy of prematurity. However, how these blood vessels form during development of the human fovea remains unclear. This research will advance our understanding of the fundamental knowledge of how the blood vessels around the fovea form in infants, and how they change in diseased states such as preterm birth or retinopathy of prematurity.

Key Dates

Start date
Oct 3, 2024
Status verified
Oct 2025
Primary completion
Aug 31, 2027
Completion
Aug 31, 2027

Study Design

Enrollment
16 participants (estimated)

Arms

  • Arm: Cohort 1
    16 preterm infants undergoing ROP screening to optimize methods to acquire and process beside infant perifoveal vascular imaging and assess rigor and reproducibility. The visits in the ICN (Intensive Care Nursery) will occur between 32 and 43 weeks post menstrual age at the time of ROP screening exams. Study visits will include, but are not limited to: * Ocular examination * OCT imaging of retinal microanatomy * OCTA imaging of retinal microvasculature * Medical and ocular history * Adverse event documentation

Primary Outcome Measure

Change in vascular density of intermediate and deep vascular plexus at the fovea and perifovea [ Time Frame: During hospitalization (at approximately 32-44 weeks post menstrual age, PMA) ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Duke UniversityDurhamNorth Carolina27710
Xi Chen, MD
919-684-8434
Michelle N McCall, MCAPM, BA
(919) 684-0544
Xi Chen, MD (PRINCIPAL_INVESTIGATOR)
Cynthia A Toth, MD (SUB_INVESTIGATOR)
Sina Farsiu, PhD (SUB_INVESTIGATOR)
University of PennsylvaniaPhiladelphiaPennsylvania19104
Gui-Shuang Ying, PhD
215-615-1514
Gui-Shuang Ying, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Durham, NC

Related Studies